Emergent BioSolutions Inc. (EBS)
NYSE · Healthcare
Emergent BioSolutions Inc. Revenue 2009–2025
Emergent BioSolutions Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Emergent BioSolutions Inc. revenue for the quarter ending March 31, 2026 was 156.1 M, a 29.75% decrease year-over-year.
- Emergent BioSolutions Inc. revenue for the twelve months ending March 31, 2026 was 750.3 M, a 32.97% decrease year-over-year.
- Emergent BioSolutions Inc. annual revenue for 2025 was 742.9 M, a 28.81% decrease from 2024.
- Emergent BioSolutions Inc. annual revenue for 2024 was 1.0 B, a 0.54% decrease from 2023.
- Emergent BioSolutions Inc. annual revenue for 2023 was 1.0 B, a 6.10% decrease from 2022.
- Emergent BioSolutions Inc. annual revenue for 2022 was 1.1 B.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Emergent BioSolutions Inc. Revenue — FAQ
Emergent BioSolutions Inc. (EBS) revenue over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Emergent BioSolutions Inc.'s revenue?
Emergent BioSolutions Inc. (EBS) reported revenue of $743M for fiscal 2025.
Where can I see EBS's revenue history?
The chart and table above show Emergent BioSolutions Inc.'s revenue by year and by quarter, including the growth rate.